HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W S Dalton Selected Research

Inflammation (Inflammations)

11/2014A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumours.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W S Dalton Research Topics

Disease

17Neoplasms (Cancer)
09/2015 - 05/2000
6Multiple Myeloma
02/2003 - 05/2000
4B-Cell Lymphoma (Lymphoma, B Cell)
12/2013 - 09/2001
4Lymphoma (Lymphomas)
12/2013 - 09/2001
1Aneuploidy (Aneuploid)
09/2015
1Carcinogenesis
09/2015
1Dehydration (Water Stress)
11/2014
1Exanthema (Rash)
11/2014
1Inflammation (Inflammations)
11/2014
1Neutropenia
11/2014
1Ovarian Neoplasms (Ovarian Cancer)
11/2014
1Serum Sickness
11/2014
1Colorectal Neoplasms (Colorectal Cancer)
11/2014
1Non-Hodgkin Lymphoma (Lymphosarcoma)
07/2007
1Residual Neoplasm
01/2007
1Leukemia
06/2003
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
09/2001
1Hematologic Neoplasms (Hematological Malignancy)
09/2001
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
08/2001
1Acute Promyelocytic Leukemia
08/2001
1Genetic Translocation (Chromosomal Translocation)
01/2001
1Breast Neoplasms (Breast Cancer)
05/2000
1Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2000

Drug/Important Bio-Agent (IBA)

6Pharmaceutical PreparationsIBA
09/2015 - 05/2000
4Mitoxantrone (Novantrone)FDA LinkGeneric
01/2009 - 05/2000
3MicroRNAs (MicroRNA)IBA
12/2013 - 01/2011
3Proteins (Proteins, Gene)FDA Link
07/2007 - 05/2000
3Fibronectins (Fibronectin)IBA
06/2003 - 01/2001
2Imatinib Mesylate (Gleevec)FDA Link
01/2007 - 08/2001
2CytokinesIBA
11/2001 - 06/2000
2Doxorubicin (Adriamycin)FDA LinkGeneric
09/2001 - 08/2000
2LigandsIBA
09/2001 - 04/2001
1Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA
09/2015
1ridaforolimusIBA
11/2014
1MK 2206IBA
11/2014
13- (4- ((4- chlorophenyl)sulfonyl)- 4- (2,5- difluorophenyl)cyclohexyl)propanoic acidIBA
11/2014
1dalotuzumabIBA
11/2014
13-deazaneplanocinIBA
12/2013
1TACI receptor-IgG Fc fragment fusion proteinIBA
01/2009
1Conditioned Culture MediaIBA
01/2009
1Small Interfering RNA (siRNA)IBA
01/2009
1B-Cell Activating FactorIBA
01/2009
1NF-kappa B (NF-kB)IBA
07/2007
1SuspensionsIBA
07/2007
1Apoptosis Regulatory ProteinsIBA
07/2007
1Integrin beta1IBA
01/2007
1Extracellular Matrix ProteinsIBA
06/2003
1TransferasesIBA
02/2003
1FTI 277IBA
02/2003
1Farnesyltranstransferase (Farnesyltransferase)IBA
02/2003
1Janus KinasesIBA
12/2001
1Etoposide (VP 16)FDA LinkGeneric
09/2001
1trioctyl phosphine oxide (TOPO)IBA
09/2001
1fas Receptor (CD95 Antigen)IBA
09/2001
1Aligeron (AS 2)IBA
08/2001
1Ascorbic Acid (Vitamin C)FDA LinkGeneric
08/2001
1DNA (Deoxyribonucleic Acid)IBA
08/2001
1tyrphostin AG957IBA
08/2001
1Arsenic Trioxide (Trisenox)FDA Link
08/2001
1Ribonucleases (Ribonuclease)IBA
04/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
04/2001
1STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
04/2001
1Complementary DNA (cDNA)IBA
08/2000
1Antineoplastic Agents (Antineoplastics)IBA
08/2000
1VaccinesIBA
06/2000
1IntegrinsIBA
06/2000
1multidrug resistance-associated protein 1IBA
05/2000
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
05/2000
1Messenger RNA (mRNA)IBA
05/2000
1Monoclonal AntibodiesIBA
05/2000
1Topotecan (Hycamtin)FDA LinkGeneric
05/2000
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
05/2000

Therapy/Procedure

5Therapeutics
09/2015 - 01/2001
5Drug Therapy (Chemotherapy)
01/2009 - 05/2000
1Radiotherapy
11/2001